DE2165373C3 - Stabilisation von antibiotischen Lösungen - Google Patents
Stabilisation von antibiotischen LösungenInfo
- Publication number
- DE2165373C3 DE2165373C3 DE2165373A DE2165373A DE2165373C3 DE 2165373 C3 DE2165373 C3 DE 2165373C3 DE 2165373 A DE2165373 A DE 2165373A DE 2165373 A DE2165373 A DE 2165373A DE 2165373 C3 DE2165373 C3 DE 2165373C3
- Authority
- DE
- Germany
- Prior art keywords
- solution
- aqueous
- sulfate
- discoloration
- aminodeoxykanamycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000003115 biocidal effect Effects 0.000 title description 15
- 230000006641 stabilisation Effects 0.000 title description 2
- 238000011105 stabilization Methods 0.000 title description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 86
- 235000011187 glycerol Nutrition 0.000 claims description 36
- YGTPKDKJVZOVCO-KELBJJLKSA-N bekanamycin sulfate Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N YGTPKDKJVZOVCO-KELBJJLKSA-N 0.000 claims description 23
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 21
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 21
- 239000003242 anti bacterial agent Substances 0.000 claims description 15
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 claims description 15
- 229940088710 antibiotic agent Drugs 0.000 claims description 14
- 229960002064 kanamycin sulfate Drugs 0.000 claims description 9
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 8
- 229930195725 Mannitol Natural products 0.000 claims description 6
- 239000000594 mannitol Substances 0.000 claims description 6
- 235000010355 mannitol Nutrition 0.000 claims description 6
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000003381 stabilizer Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 description 41
- 239000007864 aqueous solution Substances 0.000 description 40
- 238000002845 discoloration Methods 0.000 description 26
- 150000005846 sugar alcohols Polymers 0.000 description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000007423 decrease Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 5
- 229960001192 bekanamycin Drugs 0.000 description 5
- SKKLOUVUUNMCJE-FQSMHNGLSA-N kanamycin B Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SKKLOUVUUNMCJE-FQSMHNGLSA-N 0.000 description 5
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- 239000003889 eye drop Substances 0.000 description 3
- 229940012356 eye drops Drugs 0.000 description 3
- 235000010265 sodium sulphite Nutrition 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 239000003221 ear drop Substances 0.000 description 2
- 229940047652 ear drops Drugs 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940100662 nasal drops Drugs 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 229940001584 sodium metabisulfite Drugs 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- -1 nose drops Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP45121887A JPS4911403B1 (OSRAM) | 1970-12-29 | 1970-12-29 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2165373A1 DE2165373A1 (de) | 1972-08-03 |
| DE2165373B2 DE2165373B2 (de) | 1977-07-28 |
| DE2165373C3 true DE2165373C3 (de) | 1978-03-30 |
Family
ID=14822357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2165373A Expired DE2165373C3 (de) | 1970-12-29 | 1971-12-29 | Stabilisation von antibiotischen Lösungen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3904755A (OSRAM) |
| JP (1) | JPS4911403B1 (OSRAM) |
| CA (1) | CA985171A (OSRAM) |
| DE (1) | DE2165373C3 (OSRAM) |
| FR (1) | FR2120132B1 (OSRAM) |
| GB (1) | GB1365708A (OSRAM) |
| NL (1) | NL158704B (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2731013C2 (de) * | 1977-07-08 | 1982-07-15 | Lentia Gmbh | Verfahren zur Herstellung einer wäßrigen Infusionslösung |
| US4223022A (en) * | 1978-01-16 | 1980-09-16 | Schering Corporation | Stabilized aminoglycoside antibiotic formulations |
| DE102010020940B4 (de) * | 2010-05-19 | 2014-09-25 | Heraeus Medical Gmbh | Antibiotische Beschichtung |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3616243A (en) * | 1968-08-09 | 1971-10-26 | Meiji Seika Kaisha | Process for the production of an antibiotic substance 2'-amino-2'-deoxy-kanamycin in higher yield |
-
1970
- 1970-12-29 JP JP45121887A patent/JPS4911403B1/ja active Pending
-
1971
- 1971-12-28 US US213222A patent/US3904755A/en not_active Expired - Lifetime
- 1971-12-29 NL NL7118028.A patent/NL158704B/xx not_active IP Right Cessation
- 1971-12-29 GB GB6046571A patent/GB1365708A/en not_active Expired
- 1971-12-29 FR FR7147414A patent/FR2120132B1/fr not_active Expired
- 1971-12-29 CA CA131,200A patent/CA985171A/en not_active Expired
- 1971-12-29 DE DE2165373A patent/DE2165373C3/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2120132B1 (OSRAM) | 1975-10-10 |
| FR2120132A1 (OSRAM) | 1972-08-11 |
| GB1365708A (en) | 1974-09-04 |
| US3904755A (en) | 1975-09-09 |
| CA985171A (en) | 1976-03-09 |
| DE2165373A1 (de) | 1972-08-03 |
| DE2165373B2 (de) | 1977-07-28 |
| JPS4911403B1 (OSRAM) | 1974-03-16 |
| NL7118028A (OSRAM) | 1972-07-03 |
| NL158704B (nl) | 1978-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69109021T2 (de) | Augentropfenarzneimittel. | |
| DE69004066T2 (de) | Verfahren zur photostabilisierung von augenspüllösungen. | |
| DE1617521C3 (de) | Verfahren zur Herstellung von Sulfonamid-Potentiator-Lösungen | |
| DE2324386B1 (de) | Wässriger Cholesterin-Standard | |
| DE2165373C3 (de) | Stabilisation von antibiotischen Lösungen | |
| EP0143857B1 (de) | Coronartherapeutikum in Form von Weichgelatine-Kapseln | |
| DE1211357B (de) | Verfahren zum Stabilisieren von Catechinaminen | |
| DE2743586C2 (de) | Injizierbare Lösung, die L-Pyroglutamyl-L-histidyl-L-prolinamid oder ein physiologisch unbedenkliches Salz hiervon enthält | |
| EP0074620A2 (de) | Verfahren zur Stabilisierung photoinstabiler Arzneistoffe sowie stabilisierte Arzneizubereitungen | |
| DE1467749A1 (de) | Verfahren zur Herstellung von stabilen Tetracyclinpraeparaten | |
| DE1119119B (de) | Fotografisches Material mit lichtempfindlicher Halogensilberemulsionsschicht und Gehalt an Polyalkylenoxyd | |
| DE1902148A1 (de) | Farbstabilisiertes Vitamin Centhaltendes Stoffgemisch | |
| DE1667900B2 (de) | Schnell wirkende, beständige Rinderinsulinlösung | |
| DE2654709C3 (de) | Verfahren zum Stabilisieren von Baldrianextraktpräparaten | |
| DE1171266B (de) | Stabilisierung photographischer Emulsionen | |
| DE2209526A1 (de) | Coronarmittel in spezieller form sowie verfahren zu seiner herstellung | |
| DE1792448C3 (de) | Verfahren zur Herstellung von zur parenteralen Verabreichung geeigneten stabilen Lösungen von therapeutisch anwendbaren Benzodiazepinderivaten | |
| DE2618974C2 (de) | Gerbender photographischer Entwickler | |
| DE2364470A1 (de) | Farbstabilisierung parenteraler loesungen von cephalosporinen | |
| DE1618421C (de) | Stabilisiertes Manganäthylen-bisdithiocarbamat und dessen Verwendung | |
| DE3537839C2 (OSRAM) | ||
| DE68902223T2 (de) | Waesserige loesungen von doxorubicin. | |
| EP0108248B1 (de) | Lösungsvermittlerfreie, wässrige Nitroglycerinlösung | |
| AT390191B (de) | Verfahren zur herstellung von fluessigen pharmazeutischen zusammensetzungen mit einem gehalt an 2-tert.butylamino-1-(4'-hydroxy-3'hydroxymethylphenyl)-aethanol (1) | |
| DE1011663B (de) | Mittel zur Bekaempfung von Mollusken, insbesondere Schnecken |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| 8328 | Change in the person/name/address of the agent |
Free format text: KOHLER, M., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN |
|
| 8339 | Ceased/non-payment of the annual fee |